Authors: Moore, KW Bonner, K Jones, EA Emms, F Leeson, PD Marwood, R Patel, S Patel, S Rowley, M Thomas, S Carling, RW

Citation: Kw. Moore et al., 4-N-linked-heterocyclic piperidine derivatives with high affinity and selectivity for human dopamine D-4 receptors, BIOORG MED, 9(9), 1999, pp. 1285-1290

Authors: Curtis, NR Kulagowski, JJ Leeson, PD Ridgill, MP Emms, F Freedman, SB Patel, S Patel, S

Citation: Nr. Curtis et al., Synthesis and SAR of 2- and 3-substituted 7-azaindoles as potential dopamine D-4 ligands, BIOORG MED, 9(4), 1999, pp. 585-588

Authors: Atack, JR Smith, AJ Emms, F McKernan, RM

Citation: Jr. Atack et al., Regional differences in the inhibition of mouse in vivo [H-3]Ro 15-1788 binding reflect selectivity for alpha(1) versus alpha(2) and alpha(3) subunit-containing GABA(A) receptors, NEUROPSYCH, 20(3), 1999, pp. 255-262

Authors: Carling, RW Moore, KW Moyes, CR Jones, EA Bonner, K Emms, F Marwood, R Patel, S Patel, S Fletcher, AE Beer, M Sohal, B Pike, A Leeson, PD

Citation: Rw. Carling et al., 1-(3-cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A selective high-affinity antagonist for the human dopamine D-4 receptorwith excellent selectivity over ion channels, J MED CHEM, 42(14), 1999, pp. 2706-2715